Boothbay Fund Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
PA
SL
Boothbay Fund Management's ZYME Position: Q4 2025 in Review
Boothbay Fund Management sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 32,757 shares — an estimated $559K sold.
Boothbay Fund Management first reported a position in ZYME in Q2 2019 and held it in 3 quarters. The position peaked at $559K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.
- Boothbay Fund Management reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
- Boothbay Fund Management sold 32,757 Zymeworks shares in Q4 2025, an estimated $559K.
- Boothbay Fund Management first reported a position in Zymeworks in Q2 2019 and held it in 3 quarters.
- Boothbay Fund Management's Zymeworks position peaked at $559K in Q3 2025.
- 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.
Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.